Four long noncoding RNAs act as biomarkers in lung adenocarcinoma

Zhang Zhihui; Yang Liu; Li Yujiang; Wu Yunfei; Li Xiang; Wu Xu

doi:10.1515/med-2021-0276

Open Medicine (Apr 2021)

Four long noncoding RNAs act as biomarkers in lung adenocarcinoma

Zhang Zhihui,
Yang Liu,
Li Yujiang,
Wu Yunfei,
Li Xiang,
Wu Xu

Affiliations

Zhang Zhihui: Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Yang Liu: Department of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany
Li Yujiang: Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Wu Yunfei: Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China
Li Xiang: Department of Emergency Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Wu Xu: Department of Thoracic and Cardiovascular Surgery/Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Jingxi Street, Guangzhou, Guangdong 510515, China

DOI: https://doi.org/10.1515/med-2021-0276
Journal volume & issue: Vol. 16, no. 1
pp. 660 – 671

Abstract

Read online

Lung adenocarcinoma (LUAD) is currently one of the most common malignant tumors worldwide. However, there is a lack of long noncoding RNA (lncRNA)-based effective markers for predicting the prognosis of LUAD patients. We identified four lncRNAs that can effectively predict the prognosis of LUAD patients.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords